PIK3CA and nonpapillary renal cell carcinoma: When compared to other cancers, although the PI3K-AKT pathway presents a relatively low overall mutation rate in ccRCC, the overall activation (phosphorylation levels) of AKT and downstream substrates is high [24–26].